Active Biotech AB (publ) (OM: ACTI)
Health Care · Biotechnology · SE
Skr3.79
-10.82% today · -77.0% 1Y
Active Biotech AB (publ) (OM: ACTI) operates in the Biotechnology industry within the Health Care sector. The company is valued at $9.96M and employs 5 people.
Over the last twelve months the share price has lost 77.0%, trading between 3.70 and 16.82.
Tweenvest scores Active Biotech AB (publ) across four factors: quality 39/100, value 23/100. Its strongest factor is quality.
ACTI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.96M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.79
- Dividend yield
- —
- Beta (5Y)
- 1.39
- 52-week high
- Skr16.82
- 52-week low
- Skr3.70
- Avg volume (3M)
- —
- Shares outstanding
- 26.36M
- Employees
- 5
- Next earnings
- —
About Active Biotech AB (publ)
Active Biotech AB (publ), a biotechnology company, engages in the research, development, production, marketing, and sale of medical, chemical, and biotechnology products in Sweden. It is developing Tasquinimod, a small molecule immunomodulator, which is in Phase II clinical trial to treat hematological malignancies; Laquinimod, an immunomodulator for the treatment of severe inflammatory eye diseases, such as non-infectious non anterior uveitis; and Naptumomab estafenatox, a tumor targeting immunotherapy to treat patients with solid tumors. The company has collaboration with Abramson Cancer Center, University of Pennsylvania, MD Anderson Cancer Center, Texas and Stictching-Haemato-Oncologie Volwassenen Netherlands, as well as Stanford Medicine and the Global Ophthalmic Research Center. The company was incorporated in 1983 and is headquartered in Lund, Sweden.
- ISIN
- SE0029278555
- Founded
- 1983
- Listed since
- Dec 19, 2003
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| MetaVia Inc.NasdaqCM: MTVA | $10.15M | $1.34 | -12.99% |
| Nanologica AB (publ)OM: NICA | $10.09M | Skr0.28 | -9.09% |
| Chemomab Therapeutics Ltd.NasdaqCM: CMMB | $10.07M | $1.39 | +1.46% |
| Senti Biosciences Holdings, Inc.NasdaqCM: SNTI | $10.04M | $0.32 | -0.19% |
| Adaptimmune Therapeutics plcOTCPK: ADAP.Y | $9.81M | $0.04 | +45.10% |
| Zeo ScientifiX, Inc.OTCPK: ZEOX | $9.80M | $1.25 | -8.09% |
| CRISM Therapeutics CorporationAIM: CRTX | $9.69M | £0.09 | -5.13% |
| Oncotelic Therapeutics, Inc.OTCPK: OTLC | $9.61M | $0.02 | -17.00% |
Figures last refreshed Oct 4, 2026.